Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Matrixx Projects Profit, But Zicam Litigation "Storm Clouds" Could Still Rain

This article was originally published in The Tan Sheet

Executive Summary

Matrixx Initiatives believes it has emerged with a plan for returning to growth and profitability after navigating the gauntlet of an FDA warning, product recall and millions in lost revenue in fiscal 2010
Advertisement

Related Content

Matrixx Prompts Supreme Court To Consider What Firms Must Disclose
Matrixx Prompts Supreme Court To Consider What Firms Must Disclose
Matrixx Prompts Supreme Court To Consider What Firms Must Disclose
NACDS Marketplace In Brief
NACDS Marketplace In Brief
Zicam Swab Platform Takes Center Stage In Matrixx Growth Plans
Zicam Swab Platform Takes Center Stage In Matrixx Growth Plans
Matrixx Initiatives Files Suit Against FDA On Unanswered FOIA Grounds

Topics

Advertisement
UsernamePublicRestriction

Register

PS104115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel